Stockholm-based HealthTech startup Loovi has secured €1 million in funding to launch and expand its digital platform focused on preventive health and longevity, following a year of product development and pilot programs.
The round was backed by prominent investors including BackingMinds (via Susanne Najafi), Wellstreet (Sïmon Saneback), Otmore (Jarno Hottinen), Northvolt (Emad Zand), Markify (Benoit Falenius), alongside Ultan Miller and Charles Morel.
Making Preventive Health Practical And Sustainable
Loovi was founded in 2025 by Joel Grajcer and Dr. Kevin Najafi with the ambition to simplify proactive health management.
According to Co-founder and CEO Joel Grajcer, the modern health landscape is saturated with data, but individuals are often left alone to interpret complex test results and metrics. At the same time, longevity has increasingly been associated with extreme biohacking routines that are difficult to sustain.
Loovi aims to bridge that gap by making preventive health more understandable, structured and realistic for long-term adoption.
Dr. Kevin Najafi adds that the company’s focus is on shifting healthcare from reactive treatment toward early intervention. Rather than responding to diagnoses, the platform encourages users to act on early signals by combining multiple health data sources into a medically contextualized overview.
Advertisement
A Unified Platform For Longevity
Loovi positions itself as Europe’s first end-to-end digital longevity platform. The solution integrates blood biomarkers, clinical test results, physical assessments, wearable data and lifestyle metrics into a single digital environment.
An AI-powered intelligence layer analyzes these data points together to provide users with personalized guidance and explain how different factors interact over time. Beyond technology, the platform also incorporates medical support, educational content and human interaction to help users translate insights into sustainable habits.
Unlike one-off health checks, Loovi is designed as an ongoing program focused on continuity, realistic lifestyle adjustments and structured follow-up.
Part Of A Broader European Preventive Health Trend
Loovi’s raise comes amid growing investor interest in preventive and data-driven healthcare models across Europe. In 2025 and early 2026, several HealthTech startups secured funding to scale platforms focused on early detection, biomarker analysis and wearable data integration.
In Switzerland, Ahead Health raised €5.1 million to expand its clinic partnerships, while Zurich-based Aeon secured €8.2 million for its AI-powered risk profiling platform. In France, Lucis closed €7.2 million to advance AI-driven biomarker interpretation. Barcelona-based Holo raised €1 million to expand personalized lab testing and wearable integration, and Polish-American startup Mos Health secured approximately €920k for its AI-based preventive solution.
Together, these rounds total more than €21 million, highlighting strong momentum behind early detection and structured preventive care across Europe.
While Sweden has seen fewer publicly disclosed rounds in this segment, Loovi represents part of this broader shift toward proactive, data-driven health management.
Scaling Across Europe
The €1 million funding will be used to further enhance Loovi’s medical and technical capabilities, strengthen its AI infrastructure and support expansion across additional European markets.
By consolidating fragmented health data into a unified system and providing long-term, guided support, Loovi aims to empower individuals to better understand, manage and optimize their health over time.
About Loovi
Founded in 2025 in Stockholm, Loovi is a digital longevity and preventive health platform. By combining medical testing, wearable tracking, AI-driven analysis and expert guidance, the company helps individuals take proactive, science-based steps to improve long-term health and prevent lifestyle-related diseases.
